The working group life science and anti-bribery and corruption has the pleasure to invite you to their next event on March 20 at 17:000h

 “Mitigating ABAC Risks in Third-Party Relationships: A Focus on Transfers of Value to Distributors”

Date: March 26 from 17h till 18.30h

Location: Bayer Schweiz, Uetlibergstrasse 132, 8045 Zurich

Why attend?

1. Understand ABAC Risks inherent in Transfers of Value to TPRs

Learn how to identify and navigate the various ABAC risks associated with Transfers of Value (ToVs) to distributors by examining FCPA enforcement cases.

A pattern emerges whereby distributors create slush funds and/or off-book accounts, then to be used to finance bribes to secure or maintain business (such as winning contracts, influencing procurement processes, circumventing importation rules, accessing non-public bid tender information, influencing legal decisions, obtaining regulatory exemptions, avoiding contract termination, and more).

2. Recognize Risk Patterns: Discover how Third parties may exploit financial practices, such as inflated invoices and excessive commissions, to create slush funds. Understanding these patterns is essential for recognizing potential red flags in your own operations.
3. Enhance Compliance and Control Measures: Being aware of the various types of ToVs to distributors is essential for creating adequate controls and developing strong monitoring practices, to prevent and detect misconduct.

Who should attend?

This event is highly relevant not only to Compliance Professionals but also to Finance Professionals who manage transfers of value to distributors, wholesalers, and other third parties.

Attendees will gain insights into various types of Transfers of Value  such as discounts, marketing expenses, rebates, commissions, price reductions, and other reimbursements. Participants will also learn valuable lessons from FCPA enforcement cases and improve their understanding of how to create adequate controls and develop strong monitoring practices to prevent and detect misconduct.

Speaker/Presenter: Natalia Cojocaru, Senior Director of Ethics and Compliance, Novo Nordisk /International Operations.

Natalia Cojocaru is an experienced Ethics and Compliance leader with a solid foundation in compliance auditing.  Over the past 10 years in the pharmaceutical industry, she has worked extensively with International Markets where distributors are commonly used, serving both as a Business Ethics Auditor and as the Senior Director of E&C in International Operations at Novo Nordisk.

This event is limited to 25 participants. If you can no longer make it, please advise Patrick.wellens@bayer.com as soon as possible.